The NEDD8 Conjugation Pathway Inhibitor MLN4924 Activates AMPK and Induces The ER Stress/UPR-Mediated Cell Death Pathway In Acute Lymphoblastic Leukemia

被引：0
|
作者：
Leclerc, Gilles M.
Zheng, Shuhua
Swords, Ronan T.
Leclerc, Guy J.
Barredo, Julio C.
机构：
来源：
BLOOD | 2013年 / 122卷 / 21期
关键词：
D O I：
10.1182/blood.V122.21.1285.1285
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1285
引用
收藏
页数：2
相关论文
共 13 条
  • [1] THE NEDD8 ACTIVATING ENZYME INHIBITOR PEVONEDISTAT (MLN4924) INDUCES ER STRESS/UPR-MEDIATED CELL DEATH AND ALTERS THE APOPTOTIC THRESHOLD FAVORING CELL DEATH IN ACUTE LYMPHOBLASTIC LEUKEMIA
    Barredo, J.
    Leclerc, G.
    Zheng, S.
    DeSalvo, J.
    Leclerc, G.
    Swords, R.
    PEDIATRIC BLOOD & CANCER, 2015, 62 : S210 - S210
  • [2] The NEDD8 Activating Enzyme Inhibitor Pevonedistat Induces ER Stress/UPR-Mediated Cell Death and Rebalances Homeostasis of Pro- and Anti-Apoptotic Proteins in Favor of Cell Death in Acute Lymphoblastic Leukemia Cells
    Leclerc, Gilles M.
    Zheng, Shuhua
    Leclerc, Guy J.
    DeSalvo, Joanna
    Swords, Ronan T.
    Barredo, Julio C.
    BLOOD, 2015, 126 (23)
  • [3] The NEDD8 inhibitor MLN4924 increases the size of the nucleolus and activates p53 through the ribosomal-Mdm2 pathway
    Bailly, A.
    Perrin, A.
    Malhab, L. J. Bou
    Pion, E.
    Larance, M.
    Nagala, M.
    Smith, P.
    O'Donohue, M-F
    Gleizes, P-E
    Zomerdijk, J.
    Lamond, A. I.
    Xirodimas, D. P.
    ONCOGENE, 2016, 35 (04) : 415 - 426
  • [4] The NEDD8 inhibitor MLN4924 increases the size of the nucleolus and activates p53 through the ribosomal-Mdm2 pathway
    A Bailly
    A Perrin
    L J Bou Malhab
    E Pion
    M Larance
    M Nagala
    P Smith
    M-F O'Donohue
    P-E Gleizes
    J Zomerdijk
    A I Lamond
    D P Xirodimas
    Oncogene, 2016, 35 : 415 - 426
  • [5] MLN4924, an Investigational NEDD8-Activating Enzyme Inhibitor, Induces Differentiation in Acute Myelogenous Leukemia Cell Lines
    Thomas, M. P.
    Milhollen, M. A.
    Naryanan, U.
    McDonald, A.
    Fleming, M.
    Amidon, B.
    Manfredi, M.
    Smith, P. G.
    Berger, A. J.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 88 - 88
  • [6] The NEDD8-activating enzyme inhibitor pevonedistat activates the eIF2α and mTOR pathways inducing UPR-mediated cell death in acute lymphoblastic leukemia
    Leclerc, Gilles M.
    Zheng, Shuhua
    Leclerc, Guy J.
    DeSalvo, Joanna
    Swords, Ronan T.
    Barredo, Julio C.
    LEUKEMIA RESEARCH, 2016, 50 : 1 - 10
  • [7] The NEDD8-activating enzyme inhibitor MLN4924 induces G2 arrest and apoptosis in T-cell acute lymphoblastic leukemia
    Han, Kun
    Wang, Qingyang
    Cao, Huanling
    Qiu, Guihua
    Cao, Junxia
    Li, Xin
    Wang, Jing
    Shen, Beifen
    Zhang, Jiyan
    ONCOTARGET, 2016, 7 (17): : 23812 - 23824
  • [8] ACTIVITY OF MLN4924, A NOVEL FIRST IN CLASS SMALL MOLECULE INHIBITOR OF THE NEDD8 ACTIVATING ENZYME, IN PRECLINICAL MODELS OF ACUTE MYELOID LEUKEMIA
    Swords, T.
    Kelly, K.
    Smith, P.
    Mahalingam, D.
    O'Dwyer, M.
    Nawrocki, S.
    Giles, F.
    Carew, J.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 305 - 306
  • [9] MLN4924, A Novel First in Class Small Molecule Inhibitor of the Nedd8 Activating Enzyme (NAE), Has Potent Activity in Preclinical Models of Acute Myeloid Leukemia.
    Swords, Ronan T.
    Kelly, Kevin R.
    Smith, Peter G.
    Gansey, James J.
    Mahalingam, Devalingam
    Padmanabhan, Swaminathan
    O'Dwyer, Michael C.
    Nawrocki, Steffan T.
    Giles, Francis J.
    Carew, Jennifer S.
    BLOOD, 2009, 114 (22) : 423 - 423
  • [10] MLN4924 Suppresses head and neck squamous cell carcinoma progression by inactivating the mTOR signaling pathway via the NEDD8/CUL4/ TSC2 axis
    Jiang, Youfang
    Le, Fei
    Huang, Shuangling
    Chen, Xuezhong
    Deng, Ziqing
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2024, 177
12